The advantages of nanomedicine in the treatment of visceral leishmaniasis: between sound arguments and wishful thinking.

Expert Opinion on Drug Delivery
Kevin MathaJean-Pierre Benoit

Abstract

Introduction: Although life-threatening if left untreated, visceral leishmaniasis (VL) is still a neglected endemic disease in 98 countries worldwide. The number of drugs available is low and few are in clinical trials. In the last decades, efforts have been made on the development of nanocarriers as drug delivery systems to treat VL. Given the preferential intracellular location of the parasite in the liver and spleen macrophages, the rationale is sturdy. In a clinical setting, liposomal amphotericin B displays astonishing cure rates.Areas covered: A literature search was performed through PubMed and Google Scholar. We critically reviewed the main literature highlighting the success of nanomedicine in VL. We also reviewed the hurdles and yet unfulfilled promises rising awareness of potential drawbacks of nanomedicine in VL.Expert opinion: VL is a disease where nanomedicines successes shine through. However, there are a lot of obstacles on the road to developing more efficient strategies such as targeting functionalization, oral formulations, or combined therapies. And those strategies raise many questions.

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Jul 1, 1992·British Journal of Cancer·D M WoodcockW H Sawyer
Oct 1, 1991·The Journal of Antimicrobial Chemotherapy·R T ProffittJ P Adler-Moore
May 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R G Luke, J A Boyle
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M H WhiteC B Miller
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R WingardJ Lister
Jun 6, 2000·Advanced Drug Delivery Reviews·M S Shive, J M Anderson
Aug 15, 2000·Molecular and Cellular Biochemistry·D DasguptaM K Basu
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S SundarH W Murray
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·F FrézardM A Costa
Apr 18, 2001·The Journal of Biological Chemistry·D LégaréM Ouellette
Dec 26, 2001·Journal of Clinical Epidemiology·J Dunbar-Jacob, M K Mortimer-Stephens
Jan 22, 2002·The Journal of Antimicrobial Chemotherapy·Gilbert Deray
Nov 29, 2002·The New England Journal of Medicine·Shyam SundarJonathan Berman
Nov 24, 2005·International Journal of Pharmaceutics·Donald E Owens, Nicholas A Peppas
Apr 7, 2006·Expert Review of Anti-infective Therapy·Jaime Soto, Paula Soto
Jun 1, 2006·Advances in Parasitology·Jorge AlvarPiero Olliaro
Jun 9, 2006·The New England Journal of Medicine·Lesley A StevensAndrew S Levey
Oct 7, 2006·Trends in Parasitology·Jorge AlvarCaryn Bern
Sep 25, 2007·Nature Biotechnology·Hak Soo ChoiJohn V Frangioni
Apr 11, 2008·Clinical Microbiology Reviews·Jorge AlvarJavier Moreno
May 6, 2008·The Journal of Antimicrobial Chemotherapy·Krishna Das ManandharShyam Sundar
Jul 2, 2008·Expert Opinion on Drug Delivery·Eder L Romero, Maria Jose Morilla
Apr 29, 2009·The Journal of Antimicrobial Chemotherapy·Pavel GershkovichKishor M Wasan
Feb 2, 2010·Trends in Pharmacological Sciences·Paul N NewtonFacundo M Fernández
Feb 12, 2010·The New England Journal of Medicine·Shyam SundarHenry W Murray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.